日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Endocrine Resistance Score Based on Three Key Genes Predicts Prognosis and Reveals Potential Therapeutic Targets for ER+HER2- Breast Cancer

基于三个关键基因的内分泌耐药评分可预测ER+HER2-乳腺癌的预后并揭示其潜在治疗靶点

Ping, Liqin; Zhu, Lewei; Chen, Nian; Liu, Xikun; Zhong, Jirui; Sun, Xiaoqing; Tang, Hailin; Zhang, Kaiming

Noncanonical UPR factor CREB3L2 drives immune evasion of triple-negative breast cancer through Hedgehog pathway modulation in T cells

非经典UPR因子CREB3L2通过调节T细胞中的Hedgehog通路驱动三阴性乳腺癌的免疫逃逸

Zi-Jian Cao ,Jia You ,Yu-Meng Fan ,Jia-Ying Yang ,Jirui Sun ,Xiuli Ma ,Jinku Zhang ,Zhongwu Li ,Xiang Wang ,Yu-Xiong Feng

Pan-cancer characterization of C-C motif chemokine ligand 5 (CCL5) identifies its role as biomarker and therapeutic target

对CC基序趋化因子配体5 (CCL5) 的泛癌表征揭示了其作为生物标志物和治疗靶点的作用

Wenming Zhao,Jirui Sun,Bingjuan Zhou,Haizhi Qiao,Jinku Zhang

A negative feedback loop between KLF9 and the EMT program dictates metastasis of hepatocellular carcinoma

KLF9 与 EMT 程序之间的负反馈回路决定肝细胞癌的转移

Tao Wang, Limin Feng, Zhong Shi, Lixian Yang, Xiaofu Yu, Jinsong Wu, Jirui Sun, Jinku Zhang, Yuxiong Feng, Weilin Wang

c-Jun-mediated JMJD6 restoration enhances resistance of liver cancer to radiotherapy through the IL-4-activated ERK pathway

c-Jun 介导的 JMJD6 修复通过 IL-4 激活的 ERK 通路增强肝癌对放射治疗的抵抗力

Yong Liu, Aixia Sui, Jirui Sun, Yifan Wu, Fuquan Liu, Yang Yang

Locally Trapping the C-C Chemokine Receptor Type 7 by Gene Delivery Nanoparticle Inhibits Lymphatic Metastasis Prior to Tumor Resection

利用基因递送纳米颗粒局部捕获CC趋化因子受体7型,可在肿瘤切除前抑制淋巴转移

Sai An ,Karthik Tiruthani ,Ying Wang ,Ligeng Xu ,Mengying Hu ,Jingjing Li ,Wantong Song ,Hongnan Jiang ,Jirui Sun ,Rihe Liu ,Leaf Huang

MiR-942 regulates the function of breast cancer cell by targeting FOXA2

MiR-942 通过靶向 FOXA2 来调节乳腺癌细胞的功能

Jinku Zhang, Zhiqiang Zhang, Jirui Sun, Qiushuang Ma, Wenming Zhao, Xue Chen, Haizhi Qiao